Confidence in the scientific community declined among U.S. adults in 2022, a major survey shows, driven by a partisan divide in views of both science and medicine that emerged during the COVID-19 pandemic.

Overall, 39% of U.S. adults said they had “a great deal of confidence” in the scientific community, down from 48% in 2018 and 2021. That's according to the General Social Survey, a long-running poll conducted by NORC at the University of Chicago that has monitored Americans’ opinions on key topics since 1972.

An additional 48% of adults in the latest survey reported “only some” confidence, while 13% reported “hardly any,” according to an analysis of the survey by The Associated Press-NORC Center for Public Affairs Research.

The survey showed low confidence levels among Republicans as partisan gaps that emerged during the pandemic era have stuck around, said Jennifer Benz, the center's deputy director.

“It doesn’t look all that dramatic when you just look at the trends for the overall public,” Benz said. “But when you dig into that by people’s political affiliations, there’s a really stark downturn and polarization.”

Between surveys in 2018 and 2021, as the pandemic took hold, the major parties’ trust levels headed in opposite directions. Democrats reported a growing level of confidence in science in 2021 — perhaps as a “rallying effect” around things like COVID-19 vaccines and prevention measures, Benz said. At the same time, Republicans saw their confidence start to plummet.

In the 2022 survey, Democrats’ confidence fell back to around pre-pandemic levels, with 53% reporting a great deal of confidence compared with 55% in 2018. But Republicans’ confidence continued its downward trend, dropping to 22% from 45% in 2018. Confidence in medicine has also grown more polarized since 2018. That year, Democrats and Republicans were about equally likely to say they had high confidence. By 2022, though, Republicans’ confidence had fallen to 26%, while Democrats’ has remained about the same as it was before the pandemic, at 42%.

Overall, 34% of Americans reported a great deal of confidence in medicine in 2022, compared with 39% before the pandemic.

Generally, scientists have had a high level of trust compared to other groups in the U.S., said John Besley, who studies public opinion about science at Michigan State University. And even with the latest declines, confidence in science is still higher than many other institutions, he pointed out.

But the split between political parties is a cause for concern, experts said.

“You can definitely see the impact here of people taking cues from their political leaders,” Benz said.

For Sudip Parikh, CEO of the American Association for the Advancement of Science, the drops were “disappointing but not surprising.” He sees them as part of an “overall pulling apart of our communities” and a loss of trust in many institutions.

The latest survey found that distrust has grown for some other groups, too. According to the 2022 survey, confidence in the Supreme Court has plunged to its lowest level in at least 50 years. Americans also reported lower levels of trust in education, the press, major companies and organized religion.

Besley said that scientists should communicate about their motives to help show that they are trustworthy: “Not only do we have some expertise, but that also we’re using that expertise to try to make the world better,” he said.

Parikh thought the stakes are high for rebuilding trust in science — and doing so across political lines.

“Science must be bipartisan,” he said. “The causes of Alzheimer’s are the same whether you’re a Republican or a Democrat. The fusion that goes on in the sun is the same whether you live in Topeka or you live in San Francisco.”

The General Social Survey has been conducted since 1972 by NORC at the University of Chicago. Sample sizes for each year’s survey vary from about 1,500 to about 4,000 adults, with margins of error falling between plus or minus 2 percentage points and plus or minus 3.1 percentage points. The most recent survey was conducted May 5, 2022, through Dec. 20, 2022, and includes interviews with 3,544 American adults. Results for the full sample have a margin of error of plus or minus 3 percentage points.

Share:
More In Science
Our Natural Resources: Cheddar Climate Special
It’s no secret that the world is amidst a climate crisis never before seen in our time. And our excessive resource consumption is to blame. But just exactly what resources are to blame might surprise you. Hint: fossil fuels are only one part of the problem.
The Latest on the Omicron Variant, COVID Vaccine Efficacy
Dr. Robert Lahita, the director of Saint Joseph's Institute for Autoimmune and Rheumatic Diseases, joined Cheddar to discuss the latest on omicron as the new variant has popped up in more than a dozen states so far. He emphasized that vaccinations should remain the priority despite efficacy against the new variant being unknown at this point.
Tracking the Rapid Spread of the Omicron COVID-19 Variant
Six states have confirmed cases of the new Omicron coronavirus variant, and this number is expected to grow. Cheddar's Hena Doba speaks with Dr. William Schaffner, Professor of Preventive Medicine at Vanderbilt University Medical Center, on the latest developments.
World Starts Talks On Global Pandemic Plan
Just days after the detection of the Omicron variant, the World Health Organization has agreed to start the process of establishing a global pandemic treaty or accord. Amy Maxmen, senior reporter for Nature, and Dr. Samuel Scarpino, managing director for the Rockefeller Foundation's Pandemic Prevention Institute, joined Cheddar to discuss this effort and what lessons can be learned from the many COVID-19 failures as the world prepares for future pandemics.
Local Bounti Grows Into New Stage As A Public Company
Local Bounti rang the opening bell December 3 in honor of its recent trading debut on the NYSE after closing a $1.1 billion SPAC deal. The company operates an indoor growing facility in Montana and aims to transform the production and delivery of local, fresh and sustainably-grown leafy greens. Craig Hurlbert, co-founder and co-CEO of Local Bounti, joined Cheddar to discuss the company's goals as a newly publicly-traded company.
Lamborghini CEO on Record 2021 Deliveries, Transitioning Fleet to Hybrid by 2024
Stephan Winkelmann, president of Bugatti Automobiles and CEO of Lamborghini, stopped by Cheddar to talk about Lamborghini's 2021 success after the luxury automaker set a company sales record on more than 6,9000 vehicles delivered. With climate change top of mind for the auto industry, Winkelmann also talked about Lamborghini's commitment to hybridizing its entire fleet. Still, when it comes to supercars, the legacy brand isn't quite ready to give up gasoline power, and according to the CEO, three new combustion engine vehicles will be available in 2022.
Five Omicron Variant Cases Confirmed in New York
New York officials have confirmed five omicron COVID-19 cases in New York City and on Long Island after a Minnesota man who tested positive for the same variant said he attended a convention in November at the Jacob Javits Center in Manhattan.
Possible Omicron Superspreader, Shutdown Averted & Love, Hate, Ate
It's Friday at long last. Jill and Carlo cover the latest on Omicron, including a possible superspreader event in NYC. Plus, previewing the November jobs report, a new Zoom feature no one asked for, and when it's no longer a good idea to eat Thanksgiving leftovers.
Load More